Back to search
Scientific Name: Lusutrombopag
Brand Name: Mulpleta
Company Owner: Not Available
Mechanism Of Action Lusutrombopag mimics the biological actions of endogenous thrombopoietin (TPO) by acting as an agonist for the thrombopoietin receptor (TPOR) expressed on megakaryocytes. It binds to the transmembrane domain of the receptor and induces thrombocytopoiesis by targeting the same signal transduction system as that of endogenous TPO, which involves the activation of JAK and STAT pathways
Description of the Drug: Lusutrombopag is a medication used to treat thrombocytopenia in patients with chronic liver disease scheduled to have a procedure.
Protein Data Bank: Not Available
Source: DrugBank Online – Retrieved 2023-01-23 from